HKIMG
DXCM icon

Hutchens & Kramer Investment Management Group’s DexCom DXCM Stock Holding History

Hutchens & Kramer Investment Management Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,783
Closed -$202K – 122
2022
Q4 		$202K Sell
1,783
-1,071
-38% -$118K 0.15% 105
2022
Q3 		$243K Buy
2,854
+83
+3% +$7.03K 0.2% 74
2022
Q2 		$215K Sell
2,771
-149
-5% -$13.6K 0.16% 98
2022
Q1 		$388K Hold
2,920
– – 0.22% 74
2021
Q4 		$339K Buy
+2,920
New +$420K 0.21% 75

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hutchens & Kramer Investment Management Group's DXCM Position: Q1 2023 in Review

Hutchens & Kramer Investment Management Group sold out of DexCom (DXCM) in Q1 2023, closing a stake of 1,783 shares — an estimated $202K sold.

Hutchens & Kramer Investment Management Group first reported a position in DXCM in Q4 2021 and held it in 5 quarters. The position peaked at $388K in Q1 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Hutchens & Kramer Investment Management Group reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Hutchens & Kramer Investment Management Group sold 1,783 DexCom shares in Q1 2023, an estimated $202K.
  • Hutchens & Kramer Investment Management Group first reported a position in DexCom in Q4 2021 and held it in 5 quarters.
  • Hutchens & Kramer Investment Management Group's DexCom position peaked at $388K in Q1 2022.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Hutchens & Kramer Investment Management Group's 13F filing for Q1 2023, filed 10 Apr 2023.